Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Mydecine Innovations Group Inc (MYCOF) Message Board

Experts Discuss Addiction and How to Support Indiv

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 160
(Total Views: 176)
Posted On: 01/25/2022 4:45:29 PM
Avatar
Posted By: NetworkNewsWire
Experts Discuss Addiction and How to Support Individuals Battling the Disease

Researchers at the University of Virginia are conducting new research that will assist in identifying and helping individuals who are struggling with addiction, through the institution’s Center for Leading Edge Addiction Research (“CLEAR”), which develops addiction treatments.

Data from the National Center for Drug Abuse Statistics shows that between 2009 and 2019, the number of overdose-related fatalities recorded for individuals aged 15 to 24 grew to 4,777 from less than 3,400 deaths. This increase has been linked to opioid overdoses, some of which are caused by fentanyl laced cocaine.

Studies by the Addiction Center have found that in comparison to individuals who didn’t attend a full-time, four-year program, college students were more likely to abuse drugs because of increased course load, stress, peer pressure and curiosity. The center also found that students involved in Greek life were 25% more likely to experience substance abuse compared to other students.

Nassima Ait-Daoud Tiouririne, the director of CLEAR, stated that it was important to keep the field of addiction research rich with new ways and approaches of treating addiction. Among the approaches the director has implemented at the center is the opioid helpline, which is a confidential helpline that people can call for various opioid-related questions.

Ait-Daoud Tiouririne revealed that the key primary groups of individuals who called the helpline were individuals experiencing addiction and seeking help, and individuals who had been prescribed opioids and would like advice on how to avoid addiction. The director explained that most people with addiction needed somebody to talk to, to educate them as well as connect with them. Ait-Daoud Tiourine added that knowing how to respond to a loved one who was battling addiction was useful, especially with the use of opioids among students increasing. When one is approached by a loved one seeking help, avoiding accusatory language was very important, said Ait-Daoud Tiourine, because it would not be productive and would only add to the stigma surrounding addiction. The director notes that being heard is a crucial first step in recovery.

Addicted.org is another organization that’s helping fight addiction. The company has established a drug treatment center in Charlottesville to aid in the opioid epidemic. Addicted.org has also developed a treatment locator service that assists patients to find a place near them that can meet their needs for various substance abuse issues. The organization also published information about addiction to help eliminate the stigma surrounding addiction, which research has found mirrors brain disease.

Addiction is a serious condition that is affecting millions across the world, and it is commendable that various companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are devoting their energies towards coming up with effective therapies that can turn around the lives of the people afflicted by this mental health condition.

NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at https://ibn.fm/MYCOF

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer








(0)
(0)




Mydecine Innovations Group Inc (MYCOF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us